+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The significance of physical status of human papillomavirus type 16 for predicting the effectiveness of invasive cervical cancer treatment



The significance of physical status of human papillomavirus type 16 for predicting the effectiveness of invasive cervical cancer treatment



Voprosy Onkologii 59(6): 756-760



For the 83 patients with HPV 16-cancer of the cervix (cervical cancer) I-III stages it was performed a comparative analysis of primary tumor response to therapy, the clinical outcome of the disease for 3-5 years after radical treatment and an evaluation of the possible contribution in these rates of the physical status of the virus. It was shown that total tumors regression in the early stages of the observation predominate in patients with "high-integrated" virus DNA (the degree of integration > 50%) of compared with a group of patients with episomal and "low-integrated" form of the virus, but in a distant periods (3-5 years) in the first group predominate an adverse outcome of disease. This pattern is true for tumors of stage I-III, and for less common--I-II stages. It is assumed that the integration of HPV16 DNA into the cellular genome may serve as an independent predictor of clinical outcome of cervical cancer.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 056497207

Download citation: RISBibTeXText

PMID: 24624787


Related references

Analysis of human papillomavirus type 18 load and integration status from low-grade cervical lesion to invasive cervical cancer. Journal of Clinical Microbiology 47(2): 287-293, 2009

Prognostic significance of human papillomavirus (HPV) type and nuclear DNA content in invasive cervical cancer. International Journal of Gynecological Cancer 1(2): 59-67, 1991

The use of viral load as a surrogate marker in predicting disease progression for patients with early invasive cervical cancer with integrated human papillomavirus type 16. American Journal of Obstetrics and Gynecology 201(1): 79.E1, 2009

Clinical significance of human papillomavirus genotype by linear array assay in Japanese women with uterine cervical lesions and type 16 physical status by in situ hybridization. International Journal of Gynecological Cancer 19(8): 1396-1401, 2009

Human papillomavirus status in advanced cervical cancer: predictive and prognostic significance for curative radiation treatment. International Journal of Gynecological Cancer 15(2): 278-284, 2005

Physical status of human papillomavirus integration in cervical cancer is associated with treatment outcome of the patients treated with radiotherapy. Plos one 9(1): E78995, 2014

Human papillomavirus type 16 integration in cervical carcinoma in situ and in invasive cervical cancer. Journal of Clinical Microbiology 44(5): 1755-1762, 2006

Differences in human papillomavirus type distribution in high-grade cervical intraepithelial neoplasia and invasive cervical cancer in Europe. International Journal of Cancer 132(4): 854-867, 2013

Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. International Journal of Cancer 121(3): 621-632, 2007

Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical intraepithelial neoplasia across 5 countries in Asia. International Journal of Gynecological Cancer 23(1): 148-156, 2013

Analysis by multiplex PCR of the physical status of human papillomavirus type 16 DNA in cervical cancers. Journal of Clinical Microbiology 37(11): 3514-3517, 1999

Human papillomavirus 16 physical status detection in preinvasive and invasive cervical carcinoma by multiplex real-time polymerase chain reaction. Chinese-German Journal of Clinical Oncology 6(1): 72-79, 2007

Human Papillomavirus type distribution in invasive cervical cancer in Uganda. Bmc Infectious Diseases 8: 85, 2008

Significance of Human Papillomavirus Test Performance in Samples From Women With Histopathologically Confirmed Invasive Cervical Cancer. Journal of Lower Genital Tract Disease 20(3): E52, 2016

Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer. New England Journal of Medicine 341(22): 1633-1638, 1999